Cargando…

Appraising the value of evidence generation activities: an HIV modelling study

INTRODUCTION: The generation of robust evidence has been emphasised as a priority for global health. Evidence generation spans a wide range of activities including clinical trials, surveillance programmes and health system performance measurement. As resources for healthcare and research are limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woods, Beth, Rothery, Claire, Anderson, Sarah-Jane, Eaton, Jeffrey W, Revill, Paul, Hallett, Timothy B, Claxton, Karl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304099/ https://www.ncbi.nlm.nih.gov/pubmed/30613422 http://dx.doi.org/10.1136/bmjgh-2017-000488

Ejemplares similares

Practical metrics for establishing the health benefits of research to support research prioritisation
por: Woods, Beth, et al.
Publicado: (2020)

Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
por: Woods, Beth, et al.
Publicado: (2016)

Concomitant health benefits package design and research prioritisation: development of a new approach and an application to Malawi
por: Schmitt, Laetitia, et al.
Publicado: (2021)

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems
por: Woods, Beth, et al.
Publicado: (2021)

Frontloading HIV financing maximizes the achievable impact of HIV prevention
por: Anderson, Sarah‐Jane, et al.
Publicado: (2018)

Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents
por: Ciaranello, Andrea, et al.
Publicado: (2018)

PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa
por: McGillen, Jessica B, et al.
Publicado: (2016)

HIV prevention where it is needed most: comparison of strategies for the geographical allocation of interventions
por: Anderson, Sarah‐Jane, et al.
Publicado: (2017)

A risk screening tool for ethical appraisal of evidence-generating initiatives
por: Ondrusek, Nancy K., et al.
Publicado: (2015)

Optimal timing of HIV home‐based counselling and testing rounds in Western Kenya
por: Olney, Jack J, et al.
Publicado: (2018)

The importance of local epidemic conditions in monitoring progress towards HIV epidemic control in Kenya: a modelling study
por: Anderson, Sarah‐Jane, et al.
Publicado: (2018)

Methods for selecting the best evidence to inform a NICE technology appraisal on selective internal radiation therapies for hepatocellular carcinoma
por: Wade, Ros, et al.
Publicado: (2020)

The long‐term impact and value of curative therapy for HIV: a modelling analysis
por: Guzauskas, Gregory F., et al.
Publicado: (2023)

A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods
por: Rehle, Thomas, et al.
Publicado: (2015)

HIV Treatment as Prevention: Optimising the Impact of Expanded HIV Treatment Programmes
por: Delva, Wim, et al.
Publicado: (2012)

HIV Treatment as Prevention: Considerations in the Design, Conduct, and Analysis of Cluster Randomized Controlled Trials of Combination HIV Prevention
por: Boily, Marie-Claude, et al.
Publicado: (2012)

Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates
por: Eaton, Jeffrey W., et al.
Publicado: (2014)

Object recognition is enabled by an experience-dependent appraisal of visual features in the brain’s value system
por: Kozunov, Vladimir V., et al.
Publicado: (2020)

Supporting the development of a health benefits package in Malawi
por: Ochalek, Jessica, et al.
Publicado: (2018)

Response to Questionable assumptions mar modelling of Kenya home‐based testing campaigns ‐ a comment on “Optimal timing of HIV home‐based counselling and testing rounds in Western Kenya” (Olney et al. 2018)
por: Olney, Jack J, et al.
Publicado: (2019)

Does nonlocal women’s attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?
por: Wilson, Katherine C., et al.
Publicado: (2017)

Evidence for changes in behaviour leading to reductions in HIV prevalence in urban Malawi
por: Bello, George, et al.
Publicado: (2011)

Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa
por: Selinger, Christian, et al.
Publicado: (2019)

Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms
por: Ciani, Oriana, et al.
Publicado: (2018)

A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process
por: Walton, M. J., et al.
Publicado: (2019)

COVID-19: Critical appraisal of the evidence()
por: González Rodríguez, Paz, et al.
Publicado: (2021)

Headache and Psychological Comorbidities: An Appraisal of the Evidence
por: Abu-Arafeh, Ishaq
Publicado: (2023)

Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval
por: Loncharich, Michael F., et al.
Publicado: (2022)

Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries
por: Lomas, James, et al.
Publicado: (2021)

Value-based tiered pricing for universal health coverage: an idea worth revisiting
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study
por: Bórquez, Annick, et al.
Publicado: (2019)

HIV Associated Preeclampsia: A Multifactorial Appraisal
por: Naicker, Thajasvarie, et al.
Publicado: (2021)

Towards evidence‐based integration of services for HIV, non‐communicable diseases and substance use: insights from modelling
por: Dowdy, David W, et al.
Publicado: (2020)

Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study
por: Olney, Jack J, et al.
Publicado: (2016)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study
por: Smith, Jennifer A, et al.
Publicado: (2016)

The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application
por: Espinoza, Manuel A., et al.
Publicado: (2014)

Talc Inhalation in Rats and Humans: A Review and Appraisal of Available Evidence
por: Borm, Paul J.A.
Publicado: (2023)

Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives
por: Beck, Sarah C., et al.
Publicado: (2019)

Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data
por: Ochalek, Jessica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qc7itisbrshma894dovh2512hg